Fundraising Fox

Angels Santé

Angel network

Paris · Pre-Seed–Series A · 11 people tracked

Find your way into Angels Santé

2,482 people in our graph share verified history with the Angels Santé team — schools, employers, funds. One of them is your warm intro.

Ana Andreescuunlockedknows Valerie Abrell Duong · together at HP (overlapped)
×2knows the team · via Andreessen Horowitz
×2knows the team · via McKinsey & Company
×2knows the team · via Stealth Startup
knows the team · via HEC Paris
knows the team · via Université Paris Cité
Fox Verdict
Sign up to see your fit

Investment thesis

Angels Santé presents itself as the first business angel network in Europe dedicated to health. Its mission is to identify, understand and analyze emerging and promising health projects, favoring the integration of innovative solutions beneficial to patients. The network supports Biotech, Medtech and E-Health startups by drawing on its community of investors and healthcare entrepreneurs, who bring scientific, regulatory and clinical expertise to evaluate each project. It offers members exclusive, qualified dealflow within a supportive and active community, inviting executives, entrepreneurs and healthcare professionals to share resources with young innovative companies.

Source: firm website, verified Aug 3, 2026.

Stage
Pre-Seed–Series A
HQ
Paris, FR
Instruments
Equity
Tracked investments
10

Team · 11 people

from public directories
Eric Poulet· Investor
Pierre Creau· Investorin
Stephane Mendras· Investor

What they invest in

from 7 of 10 portfolio companies

Medical Devices ×6Biotech ×5Healthtech ×4AI & Machine Learning ×3Deep Tech ×2Digital Health ×2

HQs:France×5

Investments · 10 tracked

founders shown can be your intro path
Open Stent Solutionopenstentsolution.comin✓ verified

Open Stent Solution develops a percutaneous medical device for mitral and tricuspid valve replacement in cardiac patients ineligible for open-heart surgery.

BiotechDeep TechHealthtechMedical DevicesUnknown from page, FR

Co-investorsCapital Cell

Abcely

Develops innovative medical and pharmaceutical technologies for treating mucosal cancers.

Alga Therapeutics

Produces antibodies to fight cancers using micro-algae.

Austral Dxaustraldx.frin

AUSTRAL Dx develops AI-powered ultrasound technology for the medtech industry, combining expertise in artificial intelligence and ultrasound imaging with capabilities in product development, regulatory approval, and market commercialization.

AI & Machine LearningDigital HealthMedical DevicesUnknown from this page, FR

Philippe Mendels-Flandre(Co-founder & CEO)inMathieu Couade(Co-founder & CSO)inFrédéric Giral(Co-founder & CTO)in

Co-investorsKima Ventures

Hephaistos-Pharmahephaistos-pharma.frinMay 2024

HEPHAISTOS is a biopharmaceutical company developing third-generation innate immune boosters (TLR4 agonists) that convert myeloid-rich, immunotherapy-resistant tumors into immunotherapy-responsive tumors.

BiotechMedical DevicesOrsay, FR

Martine Caroff(Scientific Founder)inFrederic Caroff(CEO)inFrederique Brune(CDO)inStephan Braun(CMO)inJerome Kerzerho(CSO)inChristel Lonneux(CFO and HR)in

Co-investorsxista science venturesElaiaFemmes Business Angels

HuntX Pharma

Develops small oral molecules to prevent the onset of genetic neurodegenerative diseases.

Kimialyskimialys.comin

Kimialys provides antibody selection and kinetic characterization services using proprietary Surface Plasmon Resonance imaging (SPRi) technology and K-One surface chemistry for researchers and diagnostics developers.

AI & Machine LearningBiotechDeep TechMedical Devices

Co-investorsOctalfaSuper Capital VC

Sirius Neosightsirius-neosight.comin

Sirius NeoSight develops a patented technology that measures cell membrane fluidity using a fluorescent molecule to detect, isolate and characterise Circulating Tumour Cells (CTCs) from blood samples.

BiotechHealthtechMedical DevicesLyon, FR

Arnaud Vigneron(Co-founder)inDavid Gueyrard(Co-founder)inJean-Guillaume Lafay(Co-founder)Stéphane Legastelois(Co-founder)in

Co-investorsOctalfa

StemInovsteminov.comin

StemInov is a biotech developing WhartSep, an off-the-shelf stem cell therapy derived from umbilical cord (Wharton's jelly) cells with three complementary actions to treat severe pneumonia and sepsis.

BiotechHealthtechMedical Devices

Julie Hutin(CEO & Co-founder)Danièle Bensoussan(CSO & Co-founder)

Vulgaroovulgaroo.comin

Vulgaroo develops AI-powered solutions to improve medical understanding and diagnosis.

AI & Machine LearningDigital HealthHealthtech

Christophe Lelongin

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Angels Santé made?
Angels Santé has 9 tracked investments.
What stage does Angels Santé invest at?
Angels Santé invests at the Pre-Seed, Seed, Series A stages.
What sectors does Angels Santé focus on?
Angels Santé focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is Angels Santé located?
Angels Santé is headquartered in Paris, FR.
Who does Angels Santé co-invest with?
Angels Santé most often shares deals with Octalfa, Kima Ventures, Super Capital VC, among 4 tracked co-investors.

Images

Angels Santé photoAngels Santé photo

Similar investors

Featured in lists